Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 2
1956 2
1957 4
1958 1
1959 3
1960 2
1961 13
1962 36
1963 32
1964 25
1965 34
1966 57
1967 43
1968 48
1969 41
1970 34
1971 38
1972 42
1973 25
1974 31
1975 22
1976 33
1977 32
1978 55
1979 55
1980 70
1981 73
1982 97
1983 88
1984 98
1985 124
1986 122
1987 127
1988 142
1989 160
1990 148
1991 167
1992 190
1993 191
1994 196
1995 208
1996 277
1997 281
1998 273
1999 239
2000 313
2001 283
2002 325
2003 356
2004 345
2005 319
2006 338
2007 369
2008 356
2009 368
2010 378
2011 406
2012 514
2013 492
2014 535
2015 562
2016 612
2017 536
2018 543
2019 577
2020 661
2021 743
2022 79
Text availability
Article attribute
Article type
Publication date

Search Results

12,964 results
Results by year
Filters applied: . Clear all
Page 1
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity.
Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S. Zhang B, et al. Among authors: kobayashi t. Nature. 2021 Nov;599(7885):471-476. doi: 10.1038/s41586-021-04082-1. Epub 2021 Nov 3. Nature. 2021. PMID: 34732892 Free PMC article.
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K. Nakase H, et al. Among authors: kobayashi t. J Gastroenterol. 2021 Jun;56(6):489-526. doi: 10.1007/s00535-021-01784-1. Epub 2021 Apr 22. J Gastroenterol. 2021. PMID: 33885977 Free PMC article. Review.
CD4+ T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in thyroglobulin-immunized mice.
Yasuda Y, Iwama S, Sugiyama D, Okuji T, Kobayashi T, Ito M, Okada N, Enomoto A, Ito S, Yan Y, Sugiyama M, Onoue T, Tsunekawa T, Ito Y, Takagi H, Hagiwara D, Goto M, Suga H, Banno R, Takahashi M, Nishikawa H, Arima H. Yasuda Y, et al. Among authors: kobayashi t. Sci Transl Med. 2021 May 12;13(593):eabb7495. doi: 10.1126/scitranslmed.abb7495. Sci Transl Med. 2021. PMID: 33980577
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group.
Shen B, Kochhar GS, Navaneethan U, Cross RK, Farraye FA, Iacucci M, Schwartz DA, Gonzalez-Lama Y, Schairer J, Kiran RP, Kotze PG, Kobayashi T, Bortlik M, Liu X, Levy AN, González Suárez B, Tang SJ, Coelho-Prabhu N, Lukas M, Bruining DH, El-Hachem S, Charles RJ, Chen Y, Sood A, Mao R, Loras C, Dulai PS, Picoraro JA, Chiorean M, Lukas M, Shergill A, Silverberg MS, Sandborn WJ, Bernstein CN. Shen B, et al. Among authors: kobayashi t. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):482-497. doi: 10.1016/S2468-1253(20)30394-0. Epub 2021 Apr 17. Lancet Gastroenterol Hepatol. 2021. PMID: 33872568 Review.
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T; HAYABUSA Study Group. Kobayashi T, et al. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):429-437. doi: 10.1016/S2468-1253(21)00062-5. Epub 2021 Apr 20. Lancet Gastroenterol Hepatol. 2021. PMID: 33887262 Clinical Trial.
Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction.
Sakamoto K, Jin SP, Goel S, Jo JH, Voisin B, Kim D, Nadella V, Liang H, Kobayashi T, Huang X, Deming C, Horiuchi K, Segre JA, Kong HH, Nagao K. Sakamoto K, et al. Among authors: kobayashi t. Immunity. 2021 Oct 12;54(10):2321-2337.e10. doi: 10.1016/j.immuni.2021.09.001. Epub 2021 Sep 27. Immunity. 2021. PMID: 34582748
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T, Loftus EV Jr, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ. Vermeire S, et al. Among authors: kobayashi t. J Crohns Colitis. 2021 Aug 17:jjab133. doi: 10.1093/ecco-jcc/jjab133. Online ahead of print. J Crohns Colitis. 2021. PMID: 34402887
Guidelines for Lyme Disease Are Updated.
Auwaerter PG, Kobayashi T, Wormser GP. Auwaerter PG, et al. Among authors: kobayashi t. Am J Med. 2021 Nov;134(11):1314-1316. doi: 10.1016/j.amjmed.2021.06.051. Epub 2021 Aug 3. Am J Med. 2021. PMID: 34352248 No abstract available.
ORi™: a new indicator of oxygenation.
Ishida Y, Okada T, Kobayashi T, Uchino H. Ishida Y, et al. Among authors: kobayashi t. J Anesth. 2021 Oct;35(5):734-740. doi: 10.1007/s00540-021-02938-4. Epub 2021 Apr 26. J Anesth. 2021. PMID: 33900455 Free PMC article. Review.
12,964 results
You have reached the last available page of results. Please see the User Guide for more information.